(NP (NP (NNS Studies)) (PP (IN on) (NP (NP (DT the) (JJ biological) (NN activity)) (PP (IN of) (NP (NN triiodothyronine) (NN sulfate))))) (. .))
(S (NP-SBJ (NP-COOD (NP (JJ Hepatic) (NNS microsomes)) (CC and) (NP (VBN isolated) (NNS hepatocytes))) (PP (IN in) (NP (JJ short) (NN term) (NN culture)))) (VP (VBP desulfate) (NP (NP (NN T3) (NN sulfate)) (PRN (-LRB- -LRB-) (NP (NN T3SO4)) (-RRB- -RRB-)))) (. .))
(S (NP-SBJ-33 (PRP We)) (, ,) (ADVP (RB therefore)) (, ,) (VP (VBD wished) (S (NP-SBJ (-NONE- *-33)) (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP-SBJ (NN T3SO4)) (VP (MD could) (VP (VB mimic) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NN thyroid) (NN hormone)))) (ADVP (FW in) (FW vitro)))))))))) (. .))
(S (NP-SBJ (NN T3SO4)) (VP (VBD had) (NP (DT no) (JJ thyromimetic) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NN Ca-LRB-2+-RRB--ATPase))) (PP (IN in) (NP (JJ human) (NN erythrocyte) (NNS membranes))))) (PP (IN at) (NP (NP (NNS doses)) (NP (NP (NP (QP (RB up) (TO to) (CD 10,000) (NNS times)) (DT the) (ADJP (RB maximally) (JJ effective)) (NN dose)) (PP (IN of) (NP (NN T3)))) (PRN (-LRB- -LRB-) (NP (CD (-LRB--10-RRB- 10)) (NN (L mol))) (-RRB- -RRB-)))))) (. .))
(S (PP (IN In) (NP (NN GH4C1) (JJ pituitary) (NNS cells))) (, ,) (NP-SBJ-34 (NN T3SO4)) (VP (VBD failed) (S (NP-SBJ (-NONE- *-34)) (VP (TO to) (VP (VB displace) (NP (NN -LCB-125I-RCB-T3)) (PP (IN from) (NP (NP (JJ nuclear) (NNS receptors)) (PP (IN in) (NP-COOD (NP (JJ intact) (NNS cells)) (CC or) (NP (JJ soluble) (NNS preparations)))))))))) (. .))
(S (ADVP (RB Thus)) (, ,) (NP-SBJ (NN T3SO4)) (VP (VBD was) (RB not) (ADVP (RB directly)) (ADJP-PRD (JJ thyromimetic)) (PP (IN in) (NP (NP-COOD (CC either) (NP (DT an) (VBN isolated) (JJ human) (NN membrane) (NN system)) (CC or) (NP (DT a) (JJ pituitary) (NN cell) (NN system))) (SBAR (WHPP-35 (IN in) (WHNP (WDT which))) (S (NP-SBJ (JJ nuclear) (NN receptor) (NN occupancy)) (VP (VBZ correlates) (PP (IN with) (NP (NN GH) (NN synthesis))) (PP (-NONE- *T*-35)))))))) (. .))
(S-COOD (S (NP-SBJ (NN Thyroid) (NNS hormones)) (VP (VBP inhibit) (NP (NN -LCB-3H-RCB-glycosaminoglycan) (NN synthesis)) (PP (IN by) (NP (VBN cultured) (JJ human) (JJ dermal) (NNS fibroblasts))))) (, ,) (CC and) (S (NP-SBJ (NN T3SO4)) (VP (VBN displayed) (NP (NP (NP (QP (IN about) (CD 0.5)) (NN %)) (NP (DT the) (NN activity))) (PP (IN of) (NP (NN T3)))) (PP-TMP (IN at) (NP (CD 72) (NN h))))) (. .))
(S (NP-SBJ (JJ Human) (NNS fibroblasts)) (VP (VBD contained) (NP (NP (NP (ADVP (RB roughly)) (DT the) (JJ same) (NN level)) (PP (IN of) (NP (JJ microsomal) (NN p-nitrophenyl) (NN sulfatase) (NN activity)))) (PP (IN as) (NP (NP (DT that)) (VP (ADVP-TMP (RB previously)) (VBN observed) (NP (-NONE- *)) (PP (IN in) (NP (JJ hepatic) (NNS microsomes)))))))) (. .))
(S (NP-SBJ-36 (NP (NN Propylthiouracil)) (PRN (-LRB- -LRB-) (FRAG (NP (CD 50) (NN (L mumol)))) (-RRB- -RRB-))) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NN T3SO4)))) (, ,) (S (NP-SBJ (-NONE- *-36)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (NN deiodination)) (VP (VBD was) (RB not) (ADJP-PRD (JJ important) (PP (IN for) (NP (NP (DT this) (NN activity)) (PP (IN of) (NP (NN T3SO4))))))))))))) (. .))
(S (ADVP (RB Thus)) (, ,) (NP-SBJ (PRP it)) (VP (VBZ appears) (SBAR (WHNP (-NONE- 0)) (S (NP-SBJ-37 (NN T3SO4)) (VP-COOD (VP (VBZ has) (NP (DT no) (JJ intrinsic) (JJ biological) (NN activity))) (, ,) (CC but) (, ,) (VP (PP (IN under) (NP (JJ certain) (NNS circumstances))) (, ,) (VP (MD may) (VP (VB be) (VP (VBN reactivated) (NP (-NONE- *-37)) (PP (IN by) (NP-LGS (NN desulfation))))))))))) (. .))
